Hims & Hers reported a 49% increase in Q3 revenue to $890.4 million, driven by a 321% surge in international sales, partly due to the acquisition of Eucalyptus. However, gross margins fell sharply from 73.8% to 57.2%, and the company lost 100,000 subscribers sequentially despite higher revenue per subscriber. Adjusted EBITDA rose modestly by $4 million to $82.4 million, while free cash flow declined significantly to $26 million from $79.4 million. The company faces ongoing regulatory risks and acquisition-related obligations, leading to a downward revision of its full-year outlook and a cautious market valuation.
Following the recent cautious outlook and operational challenges at Hims & Hers, the stock price has dropped notably. On Pluang, HIMS trades at USD 20.56, down 10.37% as of Nov 10, 2026, 21:42 WIB. Despite this decline, the platform shows a strong buy interest with 100% of orders as buys and a typical hold time of 24 days.
Anthropic, the AI company behind Claude, is set to begin trading next week after ending its 15-day waiting period post-S-1 filing. The company aims to raise $80B-$100B with a valuation between $1.25T and $1.75T, potentially making it the largest IPO ...
Hims & Hers Health lowered its 2026 profit forecast for the third time this year after reporting a surprise $33 million quarterly loss. Revenue grew 49% to $890.4 million, but gross margin dropped due to a shift toward lower-margin weight-loss drugs....
The Health & Wellness Power Hour program encourages participants to start their mornings with small, manageable actions that build momentum over 21 days. This approach helps individuals establish a productive morning routine by focusing on incrementa...
Hims & Hers Health has struck a deal with Eli Lilly allowing patients to buy Lilly's GLP-1 medications, including the popular Zepbound injection and Foundayo pill, directly through Hims & Hers' telehealth platform. Previously, patients had to use Lil...
Hims & Hers Health announced a partnership with Eli Lilly to offer Eli Lilly's GLP-1 drugs through its platform, providing a significant boost to the company's stock. This agreement is seen as a much-needed positive development for Hims & Hers, poten...
